Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 Q1- Text added to 2012 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
amendsAccounting, approach, bortezomib, coupon, currentlyprescribed, EMA, farther, Goodwilland, goodwillimpairment, immunomodulatory, injection, KyprolisTM, licensee, ofAvinza, opposed, original, qualitative, registered, reportingunit, shown, survival, therapy, tofirst, underwriting
Removed:
acceleration, closed, closing, cure, delivered, derivative, EMEA, escrow, excluding, expressly, feasibility, finance, fourth, historic, hypothetical, lab, lump, main, monthly, prepayment, reached, refurbishment, released, Relief, rent, scheduled, serve, stream, sublet, subordinated, subordination, sum, utilizing, vacated
Valuein 2012 Q1 filing- Value in 2012 Q2 filing
Original filings
Filing view